Shanghai RAAS Blood Products Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 6/6
Shanghai RAAS Blood Products has a total shareholder equity of CN¥31.2B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥33.4B and CN¥2.2B respectively. Shanghai RAAS Blood Products's EBIT is CN¥2.3B making its interest coverage ratio -8.5. It has cash and short-term investments of CN¥3.7B.
Anahtar bilgiler
0%
Borç/özkaynak oranı
CN¥0
Borç
| Faiz karşılama oranı | -8.5x |
| Nakit | CN¥3.71b |
| Eşitlik | CN¥31.17b |
| Toplam yükümlülükler | CN¥2.19b |
| Toplam varlıklar | CN¥33.36b |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 002252's short term assets (CN¥9.1B) exceed its short term liabilities (CN¥2.2B).
Uzun Vadeli Yükümlülükler: 002252's short term assets (CN¥9.1B) exceed its long term liabilities (CN¥26.8M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 002252 is debt free.
Borcun Azaltılması: 002252 had no debt 5 years ago.
Borç Kapsamı: 002252 has no debt, therefore it does not need to be covered by operating cash flow.
Faiz Kapsamı: 002252 has no debt, therefore coverage of interest payments is not a concern.